Lv0
0 积分 2024-12-03 加入
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
9小时前
待确认
Asthma: epidemiology, risk factors, and opportunities for prevention and treatment
10个月前
已完结
Mepolizumab Prevents COPD Exacerbations in Trial
10个月前
已完结
Advances in Causes and Treatment of Autism
1年前
已完结
皖公网安备34019202002308
